132 related articles for article (PubMed ID: 35835379)
1. Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents.
Tan YM; Li D; Li FF; Fawad Ansari M; Fang B; Zhou CH
Bioorg Med Chem Lett; 2022 Oct; 73():128885. PubMed ID: 35835379
[TBL] [Abstract][Full Text] [Related]
2. Terpene-Functionalized Fluoroquinolones as Potential Antimicrobials: Synthesis and Properties.
Izmest'ev ES; Pestova SV; Kolesnikova AI; Baidamshina DR; Kayumov AR; Rubtsova SA
ChemMedChem; 2023 Dec; 18(24):e202300358. PubMed ID: 37872856
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antibacterial activities of KB-5246, a new tetracyclic quinolone.
Kotera Y; Mitsuhashi S
Antimicrob Agents Chemother; 1989 Nov; 33(11):1896-900. PubMed ID: 2610501
[TBL] [Abstract][Full Text] [Related]
4. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
Becnel Boyd L; Maynard MJ; Morgan-Linnell SK; Horton LB; Sucgang R; Hamill RJ; Jimenez JR; Versalovic J; Steffen D; Zechiedrich L
Antimicrob Agents Chemother; 2009 Jan; 53(1):229-34. PubMed ID: 18838594
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone.
Gargallo-Viola D; Esteve M; Llovera S; Roca X; Guinea J
Antimicrob Agents Chemother; 1991 Mar; 35(3):442-7. PubMed ID: 2039195
[TBL] [Abstract][Full Text] [Related]
6. Benzenesulfonyl thiazoloimines as unique multitargeting antibacterial agents towards Enterococcus faecalis.
Zhou XM; Hu YY; Fang B; Zhou CH
Eur J Med Chem; 2023 Feb; 248():115088. PubMed ID: 36623329
[TBL] [Abstract][Full Text] [Related]
7. Unique iminotetrahydroberberine-corbelled metronidazoles as potential membrane active broad-spectrum antibacterial agents.
Ansari MF; Tan YM; Sun H; Li S; Zhou CH
Bioorg Med Chem Lett; 2022 Nov; 76():129012. PubMed ID: 36182008
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
9. Effect of fluoroquinolone resistance selection on the fitness of three strains of Clostridium perfringens.
Park M; Sutherland JB; Kim JN; Rafii F
Microb Drug Resist; 2013 Dec; 19(6):421-7. PubMed ID: 23789809
[TBL] [Abstract][Full Text] [Related]
10. Hydrazyl hydroxycoumarins as new potential conquerors towards Pseudomonas aeruginosa.
Zhao JS; Ahmad N; Li S; Zhou CH
Bioorg Med Chem Lett; 2024 May; 103():129709. PubMed ID: 38494040
[TBL] [Abstract][Full Text] [Related]
11. Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu(2+) mediated DNA-targeting antibacterial agents.
Zhang L; Kumar KV; Geng RX; Zhou CH
Bioorg Med Chem Lett; 2015 Sep; 25(17):3699-705. PubMed ID: 26149183
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria.
Vila J; Sánchez-Céspedes J; Sierra JM; Piqueras M; Nicolás E; Freixas J; Giralt E
Int J Antimicrob Agents; 2006 Jul; 28(1):19-24. PubMed ID: 16781123
[TBL] [Abstract][Full Text] [Related]
13. Cyanomethylquinolones as a New Class of Potential Multitargeting Broad-Spectrum Antibacterial Agents.
Tan YM; Zhang J; Wei YJ; Hu YG; Li SR; Zhang SL; Zhou CH
J Med Chem; 2024 Jun; 67(11):9028-9053. PubMed ID: 38787534
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-fluoroquinolone derivatives.
Zhang YB; Feng LS; You XF; Guo Q; Guo HY; Liu ML
Arch Pharm (Weinheim); 2010 Mar; 343(3):143-51. PubMed ID: 20186866
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
Zhang T; Shen W; Liu M; Zhang R; Wang M; Li L; Wang B; Guo H; Lu Y
Eur J Med Chem; 2015 Nov; 104():73-85. PubMed ID: 26435513
[TBL] [Abstract][Full Text] [Related]
16. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB
Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
[TBL] [Abstract][Full Text] [Related]
18. Detection of antibacterial-like activity on a silica surface: fluoroquinolones and their environmental metabolites.
Lewis G; Juhasz A; Smith E
Environ Sci Pollut Res Int; 2011 Aug; 19(7):2795-801. PubMed ID: 22311580
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the novel MATE fluoroquinolone efflux pump FepA in Listeria monocytogenes is driven by inactivation of its local repressor FepR.
Guérin F; Galimand M; Tuambilangana F; Courvalin P; Cattoir V
PLoS One; 2014; 9(9):e106340. PubMed ID: 25188450
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
